The selling of 'female sexual dysfunction'.

This first conference on female sexual dysfunction (FSD) offers researchers and clinicians an important opportunity to add to the already sizeable literature on contemporary women's sexual problems. However, this opportunity is threatened by commercial domination and an excessively narrow biomedical focus which neglects the research and theory growing out of 30 years of feminist scholarship. More than lip service needs to be paid to the importance of interdisciplinary understanding. The commercial cart cannot be permitted to pull the empirical and theoretical horses as happened in the impotence/erectile dysfunction field. FSD is at a crossroads, and the women's movement is watching.